长期存在的恶性胰腺类癌用奥曲肽治疗。

Long-standing malignant pancreatic carcinoid treated with octreotide.

机构信息

Unidad de Ecoendoscopia y Eco-Doppler, Centro Médico Teknon, Barcelona, Spain.

出版信息

Rev Esp Enferm Dig. 2010 Nov;102(11):662-6. doi: 10.4321/s1130-01082010001100009.

DOI:10.4321/s1130-01082010001100009

Abstract

A male presented with a metastatic, plasma serotonin-secreting (high 5-HIAA in urine), malignant pancreatic carcinoid with a carcinoid-like syndrome, and was assessed using ultrasounds (US), computerized tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography (EUS) and Octreoscan; he sequentially received chemotherapy, interferon and octreotide, with long-term, 12-year survival after diagnosis. Given this unusual case, the second reported in our country, the overall literature is reviewed.

摘要

一位男性患者表现出转移性、血浆 5-羟色胺分泌（尿液中 5-HIAA 高）、恶性胰腺类癌伴类癌综合征，并接受了超声（US）、计算机断层扫描（CT）、磁共振成像（MRI）、内镜超声（EUS）和奥曲肽扫描评估；他先后接受了化疗、干扰素和奥曲肽治疗，在诊断后长期生存了 12 年。鉴于这种罕见病例，这是在我国报告的第二例，我们对整体文献进行了回顾。